These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4868457)

  • 21. Is it safe to try new drugs when they first come on the market?
    Mayo Clin Womens Healthsource; 2006 Oct; 10(10):10. PubMed ID: 16977278
    [No Abstract]   [Full Text] [Related]  

  • 22. Systems validation for parenteral clinical drugs--application to R&D and QC laboratories.
    Tetzlaff RF
    J Parenter Sci Technol; 1983; 37(2):45-50. PubMed ID: 6345744
    [No Abstract]   [Full Text] [Related]  

  • 23. The significance of properly designed pre-clinical studies in the clinical evaluation of new drugs.
    Garrett ER
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):6-20. PubMed ID: 4924331
    [No Abstract]   [Full Text] [Related]  

  • 24. Trials and tribulations: a primer on successfully navigating the waters of the Food and Drug Administration.
    Feinsod M; Chambers WA
    Ophthalmology; 2004 Oct; 111(10):1801-6. PubMed ID: 15465539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is it time to rethink the expanded-access programs for HIV infection?
    Amorosa V; Tebas P
    J Infect Dis; 2007 Oct; 196(7):974-7. PubMed ID: 17763316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surviving the blockbuster syndrome.
    Service RF
    Science; 2004 Mar; 303(5665):1796-9. PubMed ID: 15031490
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical trial of drugs (4): trial of drugs against angina pectoris].
    Bjorntorp P
    Lakartidningen; 1970 Jun; 67():Suppl II:73+. PubMed ID: 4921726
    [No Abstract]   [Full Text] [Related]  

  • 28. Report bias in drug research.
    Bardy AH
    Therapie; 1996; 51(4):382-3. PubMed ID: 8953813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The adverse effects of drugs: the hidden part of the iceberg].
    Roca-Cusachs A; Rodicio JL
    Med Clin (Barc); 1999 Apr; 112(13):516-7. PubMed ID: 10353120
    [No Abstract]   [Full Text] [Related]  

  • 30. Initial human trials with an investigational new drug (phase I and 2): planning an management.
    Vaidya AB; Vaidya RA
    J Postgrad Med; 1981 Oct; 27(4):197-213. PubMed ID: 7338825
    [No Abstract]   [Full Text] [Related]  

  • 31. Investigational drug tracking: Phases I-III and NDA submissions--Part I.
    Grant KL
    Hosp Pharm; 1994 Sep; 29(9):830-6, 839-44, 847-52 passim. PubMed ID: 10137064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tests for equivalence or non-inferiority--why?
    Drug Ther Bull; 2008 Jul; 46(7):55-6. PubMed ID: 18603641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Availability of emergency drugs for pharmacists.
    Graham RC
    Can Pharm J; 1981 Jan; 114(1):13-4. PubMed ID: 10317048
    [No Abstract]   [Full Text] [Related]  

  • 34. Experimental drugs: where do you stand legally?
    Marchette L
    RN; 1984 Mar; 47(3):23-4. PubMed ID: 6366999
    [No Abstract]   [Full Text] [Related]  

  • 35. Problems relating to investigational drugs.
    Kelsey O
    Pharmakotherapia; 1964; 2(1):208-12. PubMed ID: 5875715
    [No Abstract]   [Full Text] [Related]  

  • 36. Success rates for new drugs entering clinical testing in the United States.
    DiMasi JA
    Clin Pharmacol Ther; 1995 Jul; 58(1):1-14. PubMed ID: 7628176
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drugs for adults--and for the children?].
    Kalikstad B; Gramstad L
    Tidsskr Nor Laegeforen; 2005 Jun; 125(11):1470. PubMed ID: 15940308
    [No Abstract]   [Full Text] [Related]  

  • 38. [Post launch studies].
    Akaza H; Ohashi Y; Shimada Y; Ikeda T; Saijo N; Isonishi S; Hirao Y; Tsuruo T; Tsukagoshi S; Sone S; Nakamura S; Kato M; Mikami O; von Euler M; Blackledge G; Milsted B; Vose B
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):2037-48. PubMed ID: 12465411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ADMET--turning chemicals into drugs.
    Hodgson J
    Nat Biotechnol; 2001 Aug; 19(8):722-6. PubMed ID: 11479558
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical trial of drugs (2): principles and problems].
    Janson J; Johnsson G; Sölvell L
    Lakartidningen; 1970 Jun; 67():Suppl II:44+. PubMed ID: 4920749
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.